In both groups of CKD‐5D patients, we observed different strengths in the prediction of IGF1, IGFBP3, and TRIM63, which influenced the probability of the presence of vascular calcifications and the severity of cardiovascular comorbidities. This evidence concerns the gene IGFBP3 and chronic kidney disease.